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Abstract
Opioid addiction in the United Sates has reached epidemic proportions in recent years,
demanding targeted efforts in both clinical medicine and public health. This analysis outlined a
demographic profile of recent prescription pain reliever (PPR) misusers and compared those
characteristics to the population of individuals currently enrolled in addiction treatment. To
explain the difference in numbers between these two populations, reported reasons for nontreatment seeking are analyzed by demographic characteristic. This discussion reviews existing
literature profiling PPR misusers and treatment-seekers, as well as research exploring barriers to
addiction treatment. A secondary analysis was performed using data from the National Survey on
Drug Use and Health (NSDUH), collected in 2015. Recent PPR misuse (within the past 30 days)
and current treatment enrollment status was compared to a number of demographic
characteristics, exploring discrepancies between categories. Reported barriers to treatment were
evaluated by demographic characteristic. Analysis uncovered a number of high-risk demographic
groups that are proportionately represented in addiction treatment facilities: homosexuals,
divorcees, young adult males aged 18-34, and those with only a high school diploma or GED. It
is hoped that this study informs a targeted clinical and public health approach to addressing
opioid addiction.
Keywords: addiction, opioid abuse, prescription pain relievers, demographic trends
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Demographic Trends in Prescription Pain Reliever Misuse and Treatment-Seeking for Addiction
The United States has been deeply entrenched in opioid dependence and subsequent
opioid-related deaths for the past several years, overwhelming the capacity of addiction medicine
specialists. The epidemic proportion of this crisis has encouraged primary health care facilities to
enhance their capabilities for treating addiction in order to accommodate the growing numbers of
opioid-dependent patients. However, a relatively small portion of opioid-dependent patients are
willing and/or able to access such treatment (Compton, Thomas, Stinson, & Grant, 2007).
History of Pain Management and Opiate Prescribing
For centuries, medicine has attempted to reach a consensus on the management of pain,
and opioid medications have been a central player in the ongoing debate. Throughout the 19th
century, opiates were prescribed indiscriminately for the management of acute or recurring pain,
without today’s knowledge of the addictive properties of such medications (Meldrum, 2003).
Opium and morphine were commonplace for the treatment of a variety of ailments and were
even used to soothe colicky children (Brownstein, 1993).
By 1910, opioid medications had begun to be abused, elevating the street value of such
drugs (Meldrum, 2003). Oxycodone, for example, sells for $80 per 80-mg tablet today, while
hydromorphone may earn 3.3 times as much on the street (Dasgupta et al., 2013). This illustrates
the expensive nature of prescription opioid medications outside the clinical setting (Dasgupta et
al., 2013). Growing concern over the abuse potential and addictive nature of opiates triggered the
passage of the Harrison Narcotics Tax Act in 1914, which imposed restrictions on the production
and distribution of opiates (Meldrum, 2003). Under the Harrison Act, physicians became
gatekeepers for the flow of opiate medications (Alam & Juurlink, 2016). Critics of the Harrison
Act noted that its regulations impacted the manufacture and sale of opiates, but exempted the
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physician, “the greatest single factor in drug addict formation,” from legal scrutiny of their
prescribing practices (Terry, 1915, p. 518). Indeed, prescribing practices would contribute to the
growing number of opioid-dependent patients as medical attitudes toward the drugs evolved. In
the late twentieth century, most physicians recognized the potential dangers of opioid
medications and limited such prescriptions to the treatment of severe cancer-related pain,
cautious of the development of opioid tolerance and dependence (Alam & Juurlink, 2016).
However, another shift in opiate prescribing practices took place in the 1990s as a result
of evolving views on pain management in the medical field (Alam & Juurlink, 2016). Regular
assessment and treatment of pain was established as the standard of care for physician visits,
encouraging the widespread acceptance of pain as a “fifth vital sign” (Alam & Juurlink, 2016;
Lynch, 2001, p. 85).
In pursuit of the worthy goal of pain management, clinicians prescribed opioids for a
growing number of acute and chronic indications, while pharmaceutical companies encouraged
such practices and understated the potential risks of the drugs (Alam & Juurlink, 2016).
Considering pain as a vital sign, patients judged the quality of their physicians by how
effectively their pain was managed. In addition, physicians have been subjected to increasing
demands in terms of patient load, shortening the time available to counsel individual patients
(Nathan, Cohen, & Vinker, 2017). On average, primary care providers (PCPs) spend only an
hour with each patient, with a large portion (52%) of the physician’s daily workday engulfed by
documentation (Arndt, Tuan, White, & Schumacher, 2014; Arndt et al., 2017). Physicians, with
less than fifteen minutes to hear and address each patient’s concerns, found that prescribing
opioids was the easiest and most effective means of treating patients complaining of pain.
Between 1992 and 2010, the yearly dispensing of opioid medications steadily increased from
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~102 million to ~270 million prescriptions (Pezalla, Rosen, Erensen, Haddox, & Mayne, 2017).
Armed with a growing understanding of the addictive properties of opioid medications,
proponents of cautious prescribing voiced their concerns about the growing number of
prescriptions in the 2000s, leading to tightened regulation by state and federal agencies (Kolodny
et al., 2015; Webster & Grabois, 2015).
State medical boards (SMBs) receive information regarding prescriptions written by
physicians, enabling the licensing body to monitor the legitimate flow of opioid medications and
identify any aberrant prescribing habits. SMBs may also engage in disciplinary action for
problematic prescribers, an infrequent but increasingly common event (Dineen & DuBois, 2016).
In 2013, the Federation of State Medical Boards developed a framework for chronic opioid
treatment, calling for drug testing to ensure adherence to the treatment regimen and frequent
consideration of discontinuing opioids (Webster & Grabois, 2015). Recognizing a problematic
trend in opioid prescribing, the U.S. Centers for Disease Control and Prevention published new
recommendations in 2016, limiting opioid prescriptions to seven days for acute pain and
encouraging non-opioid therapy for chronic pain (Dowell, Haegerich, & Chou, 2016).
Mirroring the federal recommendations, several states are in the process of passing bills
calling for provider education on the addictive properties of opioid medications, consistent use of
prescription monitoring programs, and establishing prescription requirements for pharmacists
and physicians (Knollenberg, 2017; Nevada Assembly Committee on Health and Human
Services, 2017). As currently written, these bills contain restrictions on opioid prescribing, the
violation of which are punishable by law (Knollenberg, 2017; Nevada Assembly Committee on
Health and Human Services, 2017). In 2017, Ohio passed legislation limiting opioid
prescriptions for acute pain to seven days for adults (five days for minors), among other
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stipulations (State of Ohio Board of Pharmacy, 2017). Opioid prescription-related bills have been
considered in more than 30 states as of 2018 (Blackman, 2017).
In the face of increasingly restrictive regulatory environments and social pressure from
communities riddled with addiction, physicians curbed their prescribing habits, decreasing the
number of opioid prescriptions dispensed by 16% since 2010 (Pezalla et al., 2017). This change
in supply left many patients opioid-dependent but without a legitimate supply of medication or a
referral to specialized treatment. In this context, the opioid-dependent population turned to illicit
sources of opioids to quell their cravings and withdrawal symptoms. Today, less than a quarter of
PPR misusers receive the medication from a physician, while others are left to secure pills from
their contacts or turn to the black market (Substance Abuse and Mental Health Services
Administration [SAMHSA], 2016a).
The Opioid Crisis
As more patients grew dependent upon the prescribed opioids, the reputation of the
medications as a recreational high became more prominent on the black market (Meldrum,
2016). Heroin, a synthetic opioid originally manufactured by Bayer Pharmaceuticals in 1898,
began to be produced on the streets as a cost-effective and highly accessible alternative to
physician-prescribed opioids (Alam & Juurlink, 2016). The manufacture and distribution of
synthetic opioids roughly coincided with the sudden realization of the severe impact of opioids
on public health in the 2000s, leading to a deadly combination of existing opioid dependence,
newly restrictive prescribing, and readily available (and dangerously unregulated) street
alternatives. Street-manufactured synthetic opioids sought to deliver a more potent high,
introducing life-threateningly strong drugs, including carfentanil.
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Under these conditions, the number of deaths from opioid overdose began to climb,
becoming an ever-worsening public health crisis. In the United States (U.S.), deaths due to
opioid overdose increased by 15.6% between 2014 and 2015, and are still climbing (Rudd, Seth,
David, & Scholl, 2016). The number of U.S. opioid deaths in 2016 exceeded 64,000, illustrating
the epidemic proportions of this issue (Centers for Disease Control and Prevention, 2017). The
opioid crisis continues to demand the attention of all available responders, including the expected
health professionals, as well as law enforcement and fire personnel. In October 2017, after years
of exponentially increasing numbers of overdose deaths related to opioid use, the President of the
United States declared a nationwide public health emergency to address the opioid crisis,
mobilizing federal resources to broaden treatment options and accessibility (Office of the Press
Secretary, 2017).
Local Perspective
The author and editors of this discussion are based at Wright State University in Dayton,
Ohio, a city ravaged by the opioid crisis in recent years. As detailed in Dreamland by Sam
Quinones (2015), Columbus, Ohio served as the economic epicenter for the intersection of the
black tar heroin and illicit prescription pain reliever industries, rippling outward to Southern
Ohio and West Virginia. Dayton, in Montgomery County, is among the hardest hit by the
epidemic. Montgomery County earned the unfortunate title “Overdose Capital of America” after
seeing 362 overdose deaths in the first five months of 2017, the highest number of overdose
deaths per capita in the United States (Soboroff, 2017, p. 1; Talbot & Montgomery, 2018).
Thankfully, deaths attributable to opioid abuse in Montgomery County have slowed
toward the end of 2017, though the region still suffers (Stewart, 2018). The improvement is
credited to the monumental efforts of local agencies, including Public Health - Dayton and
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Montgomery County (PHDMC); Alcohol, Drug Addiction and Mental Health Services
(ADAMHS); Families of Addicts; and Project C.U.R.E. (Community Overdose Action Team
[COAT], 2017; Families of Addicts, 2018; Project C.U.R.E, 2018).
Statement of Purpose
This project examines the demographic characteristics of recent prescription pain reliever
(PPR) misusers in comparison to those currently enrolled in treatment for addiction, to identify
any similarities and/or discrepancies between the two populations. In addition, reported reasons
for treatment non-seeking are evaluated, identifying any demographic trends among each
category of treatment barriers.
Literature Review
Demographic Profile of Opioid Users and Treatment-seekers
Opioid users. The lifetime prevalence of any drug use disorder, according to the
National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), is 9.9% (Grant
et al., 2016). The most substantial subsets of drug use disorder patients are cannabis users (6.3%
prevalence) and cocaine users (2.4%) (Grant et al., 2016). Opioid use disorder is the third most
common subtype of drug use disorder in the United States, with a 2.1% prevalence (Grant et al.,
2016).
Opioid users are a diverse group in terms of race, socioeconomic status, and treatment
needs, among other characteristics. This heterogeneity emphasizes the need for clinicians
treating addiction to make individualized treatment decisions while understanding the broader
demography of this population. Though there is likely a significant amount of overlap, data
exists for two distinct groups of opioid users: nonmedical users and prescription users.
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Nonmedical opioid users. A nonmedical opioid user is an individual who uses opioid
drugs in a manner inconsistent with their prescription instructions or who uses illegal opioid
formulation. Prevalence of nonmedical opioid use is higher in individuals with the following
characteristics (Wu, Woody, Yang, & Blazer, 2010): age between 18 and 44, male sex,
Caucasian race, family income under $70,000/year, and a family or personal history of substance
abuse. NESARC offers insight into geographical patterns of drug use as well, noting that rates of
lifetime drug abuse or dependence are higher among residents of the Western United States and
lower in the South (Compton et al., 2007).
Additional demographic characteristics studied in association with nonmedical opioid use
include sexual identity, marital status, and education levels. In a study of college students,
lesbian, gay, or bisexual (LGB) students reported nonmedical opioid use at a rate 1.78 times
higher than their heterosexual peers (Dagirmanjian, McDaniel, & Shadick, 2017). In addition,
LGB individuals are shown to initiate misuse of all prescription drugs earlier in life and more
frequently when compared to the sexual majority (Kecojevic et al., 2012). This association is
noted in the context of heightened rates of childhood abuse in the LGB population (Kecojevic et
al., 2012). Childhood abuse is one example of an adverse childhood experience (ACE). ACEs are
associated with a myriad of poor health outcomes later in life, including substance use and
addiction (Brockie, Dana-Sacco, Wallen, Wilcox, & Campbell, 2015; Dube, Felitti, Dong, Giles,
& Anda, 2003; Reuben et al., 2016).
Marriage appears to be a protective factor against the development of mental illness,
though data on addiction specifically is limited (Williams, Frech, & Carlson, 2010). Stable
marriage is hypothesized to enhance mental health by maximizing psychosocial resources in the
context of the family and providing an individual with meaning and purpose (Williams et al.,
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2010). Exiting marriage constitutes an emotional stress that is linked to poorer mental health and
increased risk of mortality from suicide in divorced men when compared to married men (RR =
2.38; 95% CI 1.58,2.72) (Kposowa, 2000). Divorced women did not demonstrate heightened risk
compared to married women (Kposowa, 2000). For both genders, marital loss (divorce or
widowhood) is linked to higher rates of depression, which is in turn linked to a 1.8 to 2.4 times
higher rate of PPR misuse among patients with PPR prescriptions (Grattan, Sullivan, Saunders,
Campbell, & Von Korff, 2012; Simon, 2002).
The association between educational attainment and substance use has been studied in the
adolescent population. Adolescents with poor academic performance are more likely to use
tobacco, marijuana, cocaine, and alcohol and less likely to pursue higher education (Bachman et
al., 2008). In addition, substance use is associated with worsening academic performance,
suggesting a bidirectional relationship between these two variables (Bachman et al., 2008).
Gender and level of education combine to have a differential effect on use of hypnosedative
medications, including opioids. In women, primary education was associated with a 21% rate of
hypnosedative use (95% CI 16.9, 25.8) compared to a 11.1% rate (95% CI 9.4, 13.1) in females
with higher education (Teixidó-Compañó et al., 2018). Education level did not significantly
affect hypnosedative abuse among men (Teixidó-Compañó et al., 2018).
Illicit opioid users are a subset of nonmedical users whose drug of choice is an illegal
opioid formulation, including heroin. Heroin users are more likely to be of African-American
race and older than primary nonmedical users, who use legal prescription drugs in a manner
inconsistent with physician instructions (Wu et al., 2010). Interestingly, Ohio data contradicts the
national findings of NESARC regarding the racial demographics of heroin users. In a 2016
report by PHDMC, 90% of naloxone administrations were given to Caucasian patients
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(Epidemiology Section of Public Health - Dayton and Montgomery County & Ebron, 2016).
Though naloxone administration does not necessarily reflect the prevalence of heroin misuse, the
discrepancy between national and local data suggests a great deal of regional variability in the
racial profile of heroin users.
Other characteristics of heroin users include age between 18 and 25, residence in an
urban area, family income under $20,000/year, lack of health insurance, and abuse of other
substances (Jones, Logan, Gladden, & Bohm, 2015). Though the demographics of primary
nonmedical users and heroin users vary slightly, young adult males seem to comprise the
majority of the nonmedical users, based on the data available (Jones et al., 2015; Wu et al.,
2010). This demographic overlap between abusers of PPRs and heroin abusers suggests that
unsanctioned use of prescription opioids is a significant risk factor for heroin use and that the
transition to illicit use is relatively unhindered (Compton, Jones, & Baldwin, 2016)
Prescription opioid users. Though illicit opioid use is rampant, it is worthwhile to review
the characteristics of patients with legitimate opioid prescriptions who use them according to
physician instructions. Regular users of legitimately obtained opioids are more likely to exhibit
the following characteristics: no high school diploma, female sex, older age (over 55), previous
psychiatric diagnosis, and polypharmacy (five or more non-opioid prescription medications)
(Figure 1) (Kelly et al., 2008).
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Prescription Opioid Users
Nonmedical Opioid Users
(Legal Users)
Both Groups
(Abusers)
Female Sex
Male Sex
Previous
psychiatric
Age 55+
Age 18-45
diagnosis
Polypharmacy
Other substance abuse

Figure 1. Comparison of legal prescription opioid users and nonmedical opioid users (abusers).
Treatment seekers. Only a small portion of the opioid-using population has the access
and motivation to seek and treatment for opioid dependence. According to NESARC, only 8.1%
of the drug abusing population had ever enrolled in treatment (Compton et al., 2007). For the
drug-dependent population, the treatment rate was 37.9%, which offers hope that a more
substantial portion of frequent and heavy users are seeking treatment (Compton et al., 2007). The
most common treatments pursued by these individuals were provided by health care
professionals and self-help groups, such as Narcotics Anonymous (Compton et al., 2007).
Data on the demographic characteristics of treatment seekers compared to non-treatment
seekers is somewhat scarce. NESARC data identifies no social or demographic factors that
influence treatment-seeking behavior, though lifetime incidence of such behavior is more
common among the widowed or divorced and among those in the lowest income bracket
(Compton et al., 2007). One study elucidates the characteristics of first-time treatment seekers
compared to those with one or more prior treatment experiences for alcohol addiction, which
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may offer insight into the types of patients likely to have strong motivation for substance abuse
treatment (LoCastro, Potter, Donovan, Couper, & Pope, 2008). First-time treatment seekers,
research shows, are more likely to be socioeconomically stable, married, employed, and female
(LoCastro et al., 2008). Interestingly, age and race do not seem to be positively or negatively
associated with treatment-seeking (LoCastro et al., 2008).
Barriers to Treatment
Stigmatization of addiction. Many patients suffering with addiction fear seeking
treatment because of the perception of negative attitudes toward addiction held by colleagues,
family, friends and other community members. The public attitude toward mental illness is not to
condemn, but to recognize it as a condition worthy of humanistic intervention (Angermeyer &
Dietrich, 2006). However, addiction as a subcategory of mental illness is more commonly met
with rejection and blame when compared to other conditions, such as depression or anxiety
alone, though monumental public health efforts are working to reverse the stigma (Angermeyer
& Dietrich, 2006; Corrigan, Kuwabara, & O'Shaughnessy, 2009). These negative attitudes
appear to be linked to uncertainty and fear surrounding the behaviors of addicted patients
(Angermeyer & Dietrich, 2006).
Unfortunately, health care providers are not immune to negative attitudes toward
addiction. Though the opinions and beliefs of individual providers vary greatly, the general
attitude of physicians toward patients with substance use disorders is negative (van Boekel,
Brouwers, van Weeghel, & Garretsen, 2013). Factors contributing to the stigma held by
providers include the emotionally challenging nature of managing addiction, the perception of
patients with addiction as manipulative or poorly motivated, and the feelings of futility and
powerlessness to affect change that often accompany addiction (Chang, Dubbin, & Shim, 2016;
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van Boekel et al., 2013). Some providers describe addicted patients as high maintenance,
difficult to work with, and resistant to treatment, perpetuating the stigmatization of this
vulnerable population (DeFlavio, Rolin, Nordstrom, & Kazal, 2015; Lundgren, Chassler,
Amodeo, D'Ippolito, & Sullivan, 2012).
The impact of provider stigmatization of addiction goes beyond simple discomfort during
the patient-provider interaction, negatively affecting patient care. Patients who perceive negative
attitudes or discriminatory practices from their physicians are less likely to complete treatment as
a result of poor patient empowerment and subconscious effects on self-esteem (van Boekel et al.,
2013). Poor self-image can contribute to decreased perceptions of self-efficacy, an important
quality in the management of addiction. The tension that bias places on the patient-provider
relationship diminishes personal engagement for both parties, leading to suboptimal provision of
care and decreased patient morale (van Boekel et al., 2013).
Fear. When considering seeking treatment for addiction, substance-dependent patients
face great fear and uncertainty. Chung and Shek (2018) found that self-reported addicts express
fear of several aspects of treatment, illustrated in Figure 2. Treatment-related fears fall into the
general categories of program-related (maladaptation to treatment), emotional, and social factors.
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Social Factors

Loss of freedom
(75.6)

Adjustment problems
(79.5)

Disappointing family
members (79.8)

Supervision (74.9)

Self-generated
pressure (71.3)

Being agitated by
others (78.4)

Strict treatment rules
(68.6)

Losing emotional
control (63.7)

Unforeseen human
factors related to
treatment (75.9)

Not being discharged
as scheduled (64.7)

Not able to get along
with other patients
(70.2)

Punishment during
treatment (61.7)
Figure 2. Fears related to treatment seeking, from Chung and Shek (2018) (percent of
respondents verifying fear, n = 303).
These fears associated with treatment-seeking create a negative, ominous image of
professional help in the minds of substance-dependent patients. This leads to a large portion of
patients (72.6%) reporting a preference to handle their mental health or substance use problem
on their own, without professional intervention (Sareen et al., 2007).
Opioid-dependent patients may also fear the notoriously uncomfortable physical
sensations associated with detoxification and reduction/cessation of use (Dugosh et al., 2016;
Reeve et al., 2013; Stone, 2015).
Attitudinal factors. Personal beliefs and attitudinal factors have been studied as barriers
to mental health access, though data on attitudes surrounding specific addiction treatment is
scarce. The single most commonly reported reason for not seeking treatment among patients with
documented mental illness (including substance use disorder) of any severity is low perceived
need (44.8% of respondents) (Mojtabai et al., 2011).
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A substantial majority (97.4%) of mental health patients who recognize the need for
treatment cite at least one attitudinal barrier, including perceptions of low problem severity,
treatment ineffectiveness, and social stigmatization (Mojtabai et al., 2011). Structural barriers
(financial, availability, transportation, and inconvenience) were reported by less than a fourth of
mental health patients (Mojtabai et al., 2011).
Financial access. Individuals with mental illness are statistically less likely to have
adequate health insurance and mental health diagnoses are commonly comorbid with substance
use disorders (Rowan, McAlpine, & Blewett, 2013). Thus, lack of health insurance is a
substantial financial barrier for mentally ill or substance-dependent patients seeking treatment.
As the most significant payer for mental health services in the United States, Medicaid
thankfully reduces the economic burden of mental health treatment on the patients themselves,
though cost is still a concern of many insured patients (Rowan et al., 2013). The perception of
cost as a barrier increases in intensity with severity of mental illness, suggesting that the patients
most in need of assistance are least likely to be able to afford treatment (Rowan et al., 2013).
This discrepancy is highlighted when low-income individuals in the United States are compared
to those in other countries (Sareen et al., 2007). Americans are more likely than both Canadians
(AOR = 9.19, 95% CI 3.79, 22.30) and Dutch (AOR = 8.09, 95% CI 4.51, 14.52) to report any
financial concern as a barrier to mental health treatment (Sareen et al., 2007).
While patients may struggle to cover the cost of treatment, providers of addiction
treatment face financial barriers in rendering services for substance use. In light of the recent rise
in opioid dependence, PCPs have been encouraged to broaden their scope of practice to include
medication-assisted treatment (MAT) for opioid and alcohol use disorders. However, in many
cases, PCPs are not adequately compensated for the additional workload of patients with

DEMOG TRENDS PPR MISUSE & TREATMENT SEEKING

19

addiction, limiting treatment capacity. Billing and reimbursement concerns are one of the most
significant barriers cited by health agency directors and clinical supervisors attempting to
provide addiction treatment services (McGovern, Xie, Segal, Siembab, & Drake, 2006).
Financial incentives, supported by policy changes, may facilitate the adoption of addiction
screening and treatment by PCPs (Hostetter & Klein, 2017). Investment in such incentives may
be encouraged by further research demonstrating the economic favorability of addiction
treatment and the potential savings in other areas (Hostetter & Klein, 2017).
Geographical access. Even if finances are not a barrier to mental health care, some
patients are geographically separated from treatment facilities, posing another barrier to access.
Addiction treatment programs require multiple visits if the patient chooses to continue treatment
in pursuit of his or her personal goals. Transportation to these visits may be a challenge for some
patients. Lack of readily available and reliable transportation decreases convenience and
contributes to poor health care utilization (Syed, Gerber, & Sharp, 2013). Though research shows
wide variance in the percentage of patients citing transportation as a barrier to health care access,
there is a consistent portion of the general patient population without reliable transportation,
especially in rural settings (Syed et al., 2013). In fact, lack of transportation is the most
commonly reported challenge to accessing care, according to patient surveys (O'Brien,
Wielunksi, Ruppel, Stoimenoff, & Gomez, 2016; Syed et al., 2013).
Given the frequency of mental health comorbidities in opioid-dependent patients,
transportation may be an even more difficult barrier to overcome in this unique population.
SAMHSA describes potential initiatives for increasing patient access to transportation that may
be implemented alongside MAT programs to enhance treatment outcomes, including half-fare
programs for public transit or volunteer-run transportation services (SAMHSA, 2004). Non-
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emergency medical transportation is available to eligible individuals insured through Medicaid,
though patients may be unaware of these benefits (Centers for Medicare and Medicaid Services,
2016).
Access to treatment varies depending on urban or rural residence. Barring financial
concerns, urban settings tend to have a wider array of services available in close geographic
proximity to potential patients, while rural residents may struggle to find a treatment facility in
close proximity to their homes (Harley & Kim, 2018). The majority of opioid treatment
programs are location in urban areas, leaving rural residents with treatment options limited in
scope and intensity (Harley & Kim, 2018).
PPR misusers are diverse and face a number of barriers when making the decision to seek
substance abuse treatment. This analysis aims to explore the demographic profile of PPR
misusers and the characteristics that are associated with treatment-seeking. In addition, reported
reasons for treatment non-seeking are evaluated, identifying any demographic trends among each
category of treatment barriers.
Methods
This study used a secondary analysis of the publicly-available dataset gathered by the
Center for Behavioral Health Statistics and Quality (CBHSQ) through the National Survey of
Drug Use and Health (NSDUH) in the year 2015 (https://nsduhweb.rti.org/).
This study is exempt from IRB evaluation, per 45 CFR part 46 of the Human Subjects
Regulations Decision Chart 1 (Appendix A). NSDUH does provide information about living
individuals, but this study did not entail any intervention or interaction with the survey
respondents and the data was de-identified. All calculations were performed in Microsoft Excel
2016.
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PPR Misusers and Treatment Enrollees
Patterns of prescription pain reliever (PPR) misuse are diverse, but for ease of analysis,
active PPR use was compared only to absent lifetime PPR use (or ‘never-use’). Active PPR
misuse was defined as use in the past 30 days. All substance misuse data collected by NSDUH is
self-reported, with no external validation of use.
To obtain a demographic profile of PPR users, pivot tables were constructed, comparing
PPR use to select demographic characteristics. Using these tables, the prevalence of PPR misuse
and current treatment was calculated. Demographic characteristics were selected based on survey
availability and comparability to existing literature. Selected characteristics (and selected
subcategories) are shown below (Table 1). Noted variables under each characteristic were
excluded for ease of analysis and scope manageability.
Table 1
Selected Demographic Characteristics from National Survey on Drug Use and Health 2015
Demographic
Characteristic
Sexual Identity
Sex

Marital Status

Education (highest level
obtained)

Age (years)

Response Categories
-

Heterosexual
Homosexual
Male
Female
Never Married
Divorced
Widowed
Married
High school
Some college
College graduate
12-17
18-25
26-34
35-49
50-64
65+

Excluded Variables
-

Bisexual

-

n/a

-

n/a

-

Fifth, sixth, … eleventh grade
completed; Associate’s degree

-

n/a
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Table 1 (Continued)
Demographic
Characteristic

Response Categories

Race

-

White
Black
Hispanic

Total Family Income
(thousands of dollars per
year)

-

<10
10-19
20-29
30-39
40-49
50-74
75+

Excluded Variables
-

Native American/Alaska
Native, Native
Hawaiian/Other Pacific
Islander

-

n/a

The selected demographic characteristics were also studied among patients seeking
treatment for addiction to drugs or alcohol. Treatment engagement was gauged by analyzing
responses to the survey question “Are you currently receiving treatment or counseling for your
[addiction]?” The number of positive responses to this general question pertaining to drug and/or
alcohol treatment (n = 3,342) is much larger than those reporting treatment for prescription pain
reliever addiction (n = 348), allowing for a larger body of information in the analysis. Comparing
the opioid-using population to the general pool of addicted patients in treatment still offers
insight into demographic trends predicting treatment engagement.
Further analysis entailed calculating odds ratios among PPR users with certain
subcategory characteristics and investigation of underlying reasons for the increased or
decreased proportion of treatment engagement in that population. Chi-square tests were
performed as appropriate on binomial categorical variables, assuming normal distribution of
values. For chi-square testing of independence, recent PPR misusers were compared to
individuals who report never misusing PPRs to explore relationships between demographic
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characteristics and PPR abuse. Alpha (α) was set at 0.05 for determination of statistical
significance.
Reported Barriers to Treatment
The NSDUH provides some data on the reasons respondents cite for not seeking
treatment for their problematic substance use. Selection of multiple reasons was allowed. For this
analysis, specific responses from NSDUH were recoded into general categories representing
different barriers to access (Table 2).
Table 2
Barriers to Treatment – Recoded Variables
Original Barrier Cited
No health insurance
Treatment not covered on health insurance plan

Recode

Subcategory
(if applicable)

Financial

Not willing to stop using
Thought they could handle it on their own

Opinion of Use

Didn't think they needed treatment
Didn't think treatment would help
Unaware of treatment options
Fear of social stigma
Didn't want others to know they needed
treatment
Fear that treatment will interfere with job
Patient didn't have time due to other
commitments
No openings in the programs
Appropriate treatment not found
Lack of transportation, inconvenient distance

Personal

Opinion of Treatment
Lack of Knowledge of
Treatment Options
Social Concerns

Employment/Other
Responsibilities
Program
Availability
Transportation
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Frequency of each general category of reasons for not seeking treatment among those
respondents who reported recent substance abuse was calculated. In addition, subcategories of
‘personal’ reasons were expressed as sub-percentages of that group.
Results
Only 5.49% of NSDUH 2015 respondents indicated ever-abusing PPRs, which limited
the sample size available for analysis of PPR use specifically. Chi-square tests of independence
comparing recent PPR misusers to individuals who report never-misuse allowed for the use of a
larger number of data points, since the majority of survey respondents (93.47%) answered the
question regarding lifetime PPR misuse.
Demographic Profile of PPR Misusers and Treatment Enrollees
Demographic characteristics of PPR misusers were compared to individuals who are
currently enrolled in treatment (Table 3). Values represent the percentage of individuals with the
noted characteristic who also meet the criteria for recent PPR misuse and current treatment. For
example, 1.59% of heterosexual respondents report recent PPR misuse.
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Table 3
Prevalence of PPR Misuse and Treatment Enrollment by Demographic Characteristic

Characteristic

Subcategory

Sexual Identity

Heterosexual
Homosexual
Male
Female
Never married
Divorced
Widowed
Married
High
school/GED
Some college
College graduate
12-17
18-25
26-34
35-49
50-64
65+
White
Black
Hispanic
<10
$10-19
20-29
30-39
40-49
50-74
75+

Gender
Marital Status

Education
(highest level
obtained)
Age (years)

Race

Total Family
Income
(thousands of
dollars per
year)

% of subcategory
reporting recent
PPR misuse
(n = 942)
1.59
2.56
1.68
1.36
1.84
2.24
1.77
1.11

% of subcategory
currently enrolled in
addiction treatment
(n = 388)
0.73
2.00
0.80
0.57
0.91
1.34
0.95
0.38

1.95

1.02

1.96
0.98
0.88
2.16
2.00
1.61
1.09
0.28
1.66
1.13
1.41
1.87
2.00
1.89
1.71
1.40
1.47
1.07

0.92
0.29
0.28
0.76
1.25
0.86
0.52
0.08
0.80
0.33
0.51
1.25
1.01
0.94
0.71
0.30
0.58
0.47

Sexual identity. The odds of PPR misuse among homosexuals is 1.19 times higher than
that of heterosexual respondents (OR 1.19; 95% CI 0.74, 1.93). However, this finding is not
statistically significant, as the 95% confidence interval includes one.
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A chi-square test of independence was performed to analyze the relationship between
sexual identity (heterosexual or homosexual) and recent PPR misuse (compared to nevermisuse). A significant relationship was discovered, χ2(1, N = 36,484) = 7.06, p < .01.
Homosexuals were more likely to report recent PPR misuse.
Gender. Though the prevalence findings in Table 3 suggest only a minute difference in
the prevalence of PPR misuse in males (1.68%) compared to females (1.36%), the odds of PPR
misuse was found to be 1.26 higher in males (OR 1.26; 95% 1.10, 1.44). Chi-square testing of
independence supports this finding, showing a significant relationship between gender and recent
PPR misuse, χ2 (1, N = 51,089) = 11.159, p < .01. This data demonstrates that males are more
likely than females to report PPR misuse.
Marital status. Current marriage appears to be protective against misuse, with only
1.11% of married respondents reporting PPR misuse compared to 1.84% of never-married
respondents. The odds of PPR misuse among divorcees is 1.73 higher than those who have never
married (OR 1.73; 95% CI 1.34, 2.24). Among married respondents, the odds of PPR misuse is
1.31 times higher than single respondents (OR 1.31; 95% CI 1.07,1.59).
Education. College education appears to be a protective factor for PPR misuse when
compared to only a high school diploma or GED (OR 0.76; 95% CI 0.58, 0.99).
Age. The 18-25 age range comprises a larger percentage of PPR misusers (36.43%) than
treatment enrollees (28.35%), though age is somewhat evenly distributed between 18-49 in both
populations (Figure 3).

Percentage of noted population
in given age range
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40%
35%
30%
25%
20%
15%
10%
5%
0%
12-17 years

18-25

26-34

35-49

50-64

65+

Age Range (years)
PPR Misusers

Treatment Enrollees

Figure 3. Age distribution of PPR misusers and treatment enrollees.
Race. Compared to Whites, Blacks are 1.33 times more likely (95% CI 1.026, 1.75) and
Hispanics 1.6 times more likely (95% CI 1.26, 2.02) to misuse PPRs. Because the 95%
confidence intervals for these odds ratios do not include 1, these differences are statistically
significant.
Despite the heightened prevalence of PPR misuse among minorities, Blacks and
Hispanics do not comprise a proportional segment of those enrolled in treatment. Blacks are 2.72
times more likely (95% CI 1.65, 4.52) not to be in treatment when compared to Whites, while
Hispanics are 1.55 times more likely (95% CI 1.05, 2.30).
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Income. There are no outstanding differences in income among PPR misusers when
compared to treatment enrollees, though more than one-fifth of both populations are comprised

Percentage of noted population
in given income range

of relatively wealthy individuals making more than $75,000 per year (Figure 4).
25%
20%
15%
10%
5%
0%
<10

10 to 19 20-29

30-39

40-49

50-74

75+

Income Range (thousands of dollars per year)
PPR Misusers

Treatment Enrollees

Figure 4. Distribution of income range among PPR misusers and treatment enrollees.
Comparison between PPR Misuse and Treatment Enrollment
Examining the most highly represented group in each demographic subcategory, we can
gain an understanding of any discrepancies between the populations of PPR misusers compared
to treatment enrollees (Table 4).
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Table 4
Comparison of the Most Highly Represented Demographic Characteristics of PPR Misusers and
Treatment Enrollees

Characteristic

Most highly represented subcategory among:
Treatment
PPR Misusers
Enrollees
Homosexual
Homosexual
Male
Male
Divorced
Divorced
Some College
High School/GED
18-25
26-34
White
White

Sexual Identity
Gender
Marital Status
Education
Age (years)
Race
Total Family Income (thousands of
10-19
dollars per year)
Note. Bolded fields represent discrepancies between the analyzed populations.

<10

Reported Barriers to Treatment
Four hundred and forty-one (441) respondents denied seeking treatment despite recent
substance use. Three hundred and seventy-four (374) responses citing a reason for nontreatment-seeking were recorded. Among the 374 responses from non-treatment seekers, 257
(68.72%) reported personal reasons, 73 (19.52%) cited financial reasons, 25 (6.68%) cited
transportation concerns, and 19 (5.08%) reported program availability factors (Figure 5).
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19.5

Financial
5.1
6.7

Program Availability
Transportation
Personal

68.7

Figure 5. Reasons cited for not seeking treatment for addiction (percentage of respondents).
Personal reasons comprised over two thirds of responses, warranting further
investigation. The majority of users in this category (n = 134, 52.2%) avoided treatment
enrollment based their personal opinions and feelings towards their substance use. These users
were not ready/willing to stop using, didn’t believe their use required treatment, or believed that
they could manage their use without professional interevention. Other subcategories of personal
reasons for avoiding treatment include social concerns (n = 47, 18.3%), employment and other
responsibilities (n = 40, 15.6%), and opinions of treatment efficacy (n = 7, 2.7%) (Figure 6).
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Opinion of Use

15.6

Opinion of Treatment
18.3

52.2

Lack of Knowledge of
Treatment Options
Social Concerns

11.3

Employment/Other
Responsibilities
2.7

Figure 6. Subcategories within "personal" reasons for not seeking treatment (percentage of
respondents citing personal reasons).

Barriers to treatment by demographic. Exploring each category of reasons for
avoiding addiction treatment by demographic characteristic allows for comparison. Table 5
shows the percentage of individuals bearing a certain demographic characteristic reporting each
category of barriers to treatment. The same information is visualized in a series of charts in
Appendix B.
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Table 5
Percentage of Demographic Subcategory Reporting Each Type of Reason for Not Seeking
Treatment
Category

Subcategory

Heterosexual
Homosexual
Male
Gender
Female
Never married
Divorced
Marital
Widowed
Status
Married
High
Education
school/GED
(highest
Some college
level
College
obtained)
graduate
12 to 17
18-25
26-34
Age
(years)
35-49
50-64
65+
White
Black
Race
Hispanic
<10
Total
$10-19
Family
20-29
Income
30-39
(thousands
40-49
of dollars
50-74
per year)
75+
Sexual
Identity

n of
Financial
subcategory
(%)
301
18.6
11
18.2
188
20.2
186
18.8
229
18.3
47
25.5
19
15.8
72
20.8

Personal
(%)
69.8
45.5
67.0
70.4
68.1
61.7
84.2
69.4

Program
(%)
4.3
27.3
6.4
3.8
6.1
6.4
0.0
2.8

Transport
(%)
7.3
9.1
6.4
7.0
7.4
6.4
0.0
6.9

98

19.4

72.4

3.1

5.1

123

18.7

68.3

5.7

7.3

32

21.9

62.5

6.3

9.4

17
132
120
75
26
4
229
49
54
50
82
42
49
47
56
48

17.6
14.4
21.7
25.3
19.2
25.0
16.2
26.5
25.9
16.0
28.0
16.7
24.5
17.0
17.9
10.4

82.4
72.0
65.8
66.7
69.2
25.0
72.5
61.2
63.0
70.0
56.1
66.7
65.3
72.3
73.2
85.4

0.0
6.8
3.3
5.3
3.8
25.0
4.8
4.1
7.4
4.0
6.1
9.5
4.1
8.5
3.6
0.0

0.0
6.8
9.2
2.7
7.7
25.0
6.6
8.2
3.7
10.0
9.8
7.1
6.1
2.1
5.4
4.2

Given the prevalence, a demographic analysis of each subtype of personal reasons is
justified (Table 6). Again, values represent percentage of the demographic subcategory citing the
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noted reason. The sample size of individuals bearing each demographic characteristic is shown in
the previous table.
Table 6
Subtype of Personal Reasons Cited, by Demographic Characteristic

Category

Subcategory

Heterosexual
40
Homosexual
33
Male
47
Gender
Female
35
Never married
19
Divorced
27
Marital
Status
Widowed
47
Married
74
Education High
school/GED
39
(highest
Some college
38
level
obtained)
College graduate
67
12 to 17
50
18-25
34
26-34
44
Age
(years)
35-49
43
50-64
57
65+
0
White
42
Black
Race
43
Hispanic
33
<10
42
Total
$10-19
34
Family
20-29
43
Income
30-39
27
(thousands
40-49
35
of dollars
50-74
48
per year)
75+
55
Note. Tx = treatment, Resp. = responsibilities.
Sexual
Identity

3
0
3
4
6
5
0
0

Unaware
of Tx
Options
(%)
12
33
14
14
19
18
7
9

4

11

6
0
0
6
3
0
0
0
1
13
3
4
0
0
12
3
0
6

19
11
0
18
9
14
14
100
16
13
13
8
8
22
19
16
19
9

Opinion
Opinion
of Use
of Tx (%)
(%)

Social
Concerns
(%)

Other
Resp. (%)

23
33
17
28
30
27
33
7

22
0
19
19
27
23
13
10

22
23
11
50
25
20
19
14
0
23
13
23
23
32
17
23
26
19
15

24
14
11
0
16
23
24
14
0
18
17
27
23
26
17
19
19
13
15
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Discussion
Demographic Findings
Sexual identity. Consistent with the literature, sexual minorities are more likely to report
PPR misuse (Kecojevic et al., 2012; Dagirmanjian et al., 2017). One hypothesized reason for this
association is the increased incidence of childhood abuse among LGB individuals, creating
lifelong psychological distress that predisposes to substance abuse as a coping mechanism.
Gender. This analysis supports the well-studied notion that men are two to three times
more likely to engage in substance abuse when compared to women, though female patients
progress more quickly in their addiction and seek treatment earlier (Becker & Hu, 2008;
Hernandez-Avila, Rounsaville, & Kranzler, 2004). The higher prevalence of substance abuse
disorders among men is thought to be linked to increased risk-taking behavior in males (Becker,
McClellan, & Reed, 2017; Charness & Gneezy, 2012). Though men are overrepresented in
treatment enrollment in this study, recovery outcomes are similar between genders after
completing a program for the treatment of addiction (Becker et al., 2017).
Marital status. Compared to singlehood, marriage appears to confer protection against
PPR misuse while divorce is associated with an increased likelihood of abuse. Widowhood and
singlehood show similar rates of PPR misuse and treatment enrollment. This suggests that
marital loss (divorce or widowhood) alone does not increase the likelihood of PPR misuse, but
divorce specifically is a risk factor.
As noted above, marriage is thought to protect against substance abuse and other risky
behavior by providing the individual with a sense of purpose, trust, and responsibility (Williams
et al., 2010). Conversely, the dissolution of a marriage through divorce is an emotional stress that
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can be detrimental to mental health, predisposing an individual to substance abuse (Williams et
al., 2010).
Interestingly, marital separation does not affect only the divorcee, but the children of the
divorced couple. Marital conflict and divorce mediates substance use and other delinquent
behaviors in children and adolescents by compromising the emotional support system and
reducing the stringency of parental monitoring (Vanassche, Sodermans, & Matthijs, 2014).
Education. College educated individuals are less likely to misuse PPRs, while those with
only a high school education or GED show a higher rate of misuse. Potential explanations for
this finding include:
-

Higher levels of education may confer a heightened awareness of the dangers of
substance abuse, discouraging initiation of use.

-

College education may lead to employment with better health-related benefits and a
stronger workplace support system, protecting against substance abuse.

-

Lower education levels may correlate with a decreased likelihood of engaging with
preventive medicine (Zhang, Too, & Irwin, 2000), distancing those with a high
school education or GED from wellness services that might circumvent substance
use.

Age. Adolescents represent a high-risk population for substance use given their
neurodevelopmental stage. Further increasing the risk of adult substance abuse and dependence
among adolescents is the initiation of substance use during childhood or adolescence (Grant,
Stinson, & Harford, 2001). Though alcohol and marijuana are the most commonly abused
substances among adolescents, use of oxycodone and over-the counter cough/cold medications
(containing dextromethorphan) is rising (Sanchez-Samper & Knight, 2009).
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Young adults comprise a significant portion of PPR misusers and treatment enrollees,
while the 50+ population rarely misuses PPRs. Notably, older adults over age 55 are frequent
patients of legitimate PPR therapy.
Race. The majority of PPR misusers are White, though racial disparities appear when
evaluating the treatment-seeking population. Hispanic and Black patients are proportionately
more likely to be uninsured, hindering the procurement of health services, especially specialty
care such as addiction treatment (National Center for Health Statistics, 2016). Historically, racial
minorities were significantly less likely to access general health care, though the Affordable Care
Act (ACA) appears to have improved such disparities (Weissman, Russell, Jay, & Malaspina,
2018).
Income. Low-income individuals (less than $19,000 per year) are most likely to be
enrolled in addiction treatment. These individuals are often insured through Medicaid, the largest
single payer for mental health services (Rowan et al., 2013). Wealthier individuals are
underrepresented among treatment enrollees, suggesting that a higher salary does not necessarily
confer a better ability to pay for treatment.
Comparison between PPR Misuse and Treatment Enrollment
Table 4 shows that PPR misusers and treatment enrollees share similar characteristics. In
both groups, the following characteristics are overrepresented: homosexual, male, divorced, and
White. Some variation between the populations is seen in education, age, and income. However,
since the values of the variant characteristics are contiguous (e.g., ages 18 to 25 and 26 to 34),
these differences may not be demographically significant.
Instead of considering these discrepancies representative of variance between the
populations of PPR misusers and treatment enrollees, the most frequent values of education, age

DEMOG TRENDS PPR MISUSE & TREATMENT SEEKING

37

and income can be combined into a single demographic profile: White, homosexual, divorced
males between the ages of 12 and 34 who have earned a high school diploma or GED and make
under $19,000/year. These characteristics represent the highest-risk population for PPR misuse
and a significant portion of treatment enrollees. This analysis reveals that demographic groups at
higher risk for PPR misuse are, in general, taking advantage of addiction treatment at rates
proportional to use.
Barriers to Treatment
Consistent with existing literature, personal (attitudinal, internal) factors are most
commonly cited as reasons for not seeking addiction treatment despite recent substance abuse.
This suggests that a large portion of people with mental health diagnoses and potential comorbid
substance use remain in the precontemplation stage of change with regard to their mental health
(Prochaska, 2013).
Based on Table 5, the following observations are noted:
-

Homosexual individuals are more likely to cite program availability factors.
Treatment facilities often lack services tailored to the LGB experience, which
may deter homosexual patients.

-

Males and females cite financial, personal, program, and transport factors at
similar rates.

-

Divorcees report financial barriers more frequently than their single, married, or
widowed counterparts, while widows are more likely to report personal factors.
Financial instability is common after divorce, especially among women, which
may explain this finding (Amato, 2010; Callens & Croux, 2009; Heath & Kiker,
1992).
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Despite the enhanced earning potential associated with a higher level of
education, the proportion of college-educated individuals reporting financial
barriers to treatment is similar to that of high school graduates and GED
recipients.

-

Adolescents and young adults (ages 12 to 25) are less likely than their older
counterparts to cite financial barriers, perhaps because they are relying on parental
contributions (through insurance or independent wealth) to pay for treatment.

-

The distribution of reason categories among the 65+ age group is not significant
because of the n of four.

-

Racial minorities (Hispanics and Blacks) are more likely to report financial
difficulties than Whites. In Blacks, financial distress may be linked to the higher
proportion noting transportation concerns.

-

High income is, not surprisingly, associated with fewer financial concerns when
approaching treatment for addiction. There does not appear to be a discernable
pattern in reason categories across income ranges.

In general, financial barriers appear to be the most cited factor for not seeking treatment,
though personal reasons are still most frequent across the board. Further analysis of the subtypes
of personal reasons by demographic characteristics yields the following observations:
-

Homosexual individuals are less likely than their heterosexual counterparts to
believe that treatment will not help their condition and to feel that treatment
would interfere with other responsibilities.
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Women report social concerns (stigmatization or fear that others will learn of their
addictions) at a higher rate than men. Men, on the other hand, are less likely to
report readiness or a need for treatment.

-

Married individuals cite opinions of use as reasons for non-treatment seeking
more often than single, divorced, or widowed respondents.

-

College graduates are more likely to report low need or readiness for treatment,
while those with only a high school diploma or GED report employment concerns
or lack of time more frequently.

-

No discernable pattern of personal reasons for non-treatment seeking is seen
across age or income ranges.

-

White and Black PPR misusers report each subtype of personal reason at similar
rates. Hispanics, however, are more likely to cite other responsibilities as a barrier
to treatment.

Implications for Public Health
Though barriers to addiction treatment are often internal to the individual, public health
agencies play a critical role in health education and prevention. The findings of this study inform
public health efforts by providing a demographic picture of the high-risk population, allowing for
a targeted community-level intervention addressing personal, financial, and transport concerns
(Figure 7). Program availability factors may be addressed by treatment facilities.
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Partnership
with Local
Agencies

Figure 7. Role of public health in addressing personal, financial, and transport barriers to
addiction treatment.
As noted below, personal barriers to treatment are often most appropriately addressed at
an individual level. However, education on emotional coping skills and alternatives to substance
use contributes to prevention efforts. Such education can be tailored to high-risk groups and
presented in partnership with local groups (including community-based organizations and
Alcohol, Drug Addiction, and Mental Health Services). For example, public health professionals
may speak on coping skills to a divorce recovery support group, strengthening the ability of the
clients to cope with their loss in a healthy manner and offering resources for those who may
already be using. In addition, due to the wide reach of public health, agencies can serve as an
informational hub for those struggling with addiction or at risk for substance use/abuse. One
aspect of this effort may be the provision of referrals to one-on-one counseling, so that
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underlying individual emotional concerns may be addressed early in the trajectory of use. The
Community Overdose Action Team (COAT) in Dayton, Ohio, serves as a landmark example of
an agency integrating local resources to educate the public on the subject of addiction and
minimize personal barriers to treatment. The education and information branch of COAT reaches
out to patients after overdose to offer information about services, and partners with such agencies
as the Montgomery County Drug-Free Coalition to expand outreach services (COAT, 2017).
A significant portion of PPR misusers report financial barriers to seeking addiction
treatment. Expanded treatment access to the uninsured or underinsured populations is largely a
policy concern, addressed by such legislature as the ACA. Public health professionals carry a
unique perspective on the impact of health policy on the wellness of communities and can
advocate for expanded health insurance systems that include mental health and addiction
services. In addition, public health agencies may engage in educational efforts to promote health
literacy and understanding of existing insurance coverage and benefits. This will help inform
patients of available treatment options and minimize financial barriers.
Transportation is a difficult barrier to address, especially in rural areas with limited public
transit. In urban settings, partnerships between public health agencies and public transit
authorities may contribute to the development of, for example, half-fare public transit programs
for health-related transportation. For rural areas with no specialized treatment facilities,
outpatient addiction services may be integrated into local primary care establishments to reduce
the travel needed to access treatment.
PPR misuse is highly prevalent in the United States, but heroin, fentanyl, and potent
fentanyl analogs are responsible for the majority of opioid-related overdose deaths. The vast
majority (79.5%) of recent heroin users report previous PPR misuse, illustrating PPR misuse as a

DEMOG TRENDS PPR MISUSE & TREATMENT SEEKING

42

significant risk factor for the initiation of intravenous opioid abuse (Muhuri, Gfroerer, & Davies,
2013). Thus, understanding the demographic characteristics of PPR misusers allows public
health agencies to address both PPR and illicit opioid use in a targeted manner.
Implications for Clinical Practice
Public health and health policy efforts toward addiction treatment are more often focused
toward removing structural barriers such as finance or transportation. These crucial efforts target
only a subset of barriers faced by potential patients of addiction treatment. Since the majority of
recent PPR misusers who are not in addiction treatment cite personal opinions of the severity of
their own use or their need/desire for treatment, individual counseling by clinicians may be an
effective approach to the opioid crisis and addiction in general.
Prochaska’s (2013) Transtheoretical Model of Behavioral Change provides a framework
for the evaluation and counseling of PPR-misusing patients. This analysis demonstrates that a
large portion of PPR misusers are in the precontemplation stage of change, unaware of the
problematic nature of their use or its potential dangers (Prochaska, 2013). These users may be
unwilling to address their behaviors and thoughts surrounding PPR use, may feel demoralized by
previous relapses, or may simply fear the uncertainty of treatment, as suggested by the literature
reviewed above.
The role of the clinician, e.g. a PCP or counselor, is to aid the patient in his or her
transition from the pre-contemplative to the contemplative stage of change, as appropriate
(Prochaska, 2013). This process begins with the establishment of a trusting, long-term
relationship in which the patient feels comfortable sharing details of his or her health behaviors.
The findings of this study reveal demographic trends in PPR misuse that are associated with past
trauma or ACEs, illustrating a population in both physical and emotional pain. Provider
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understanding of lifetime stress and trauma as a social determinant of behavioral health eases the
provision of compassionate, informed, and effective care. By fostering a nonjudgmental
environment and regularly screening for behavioral or emotional risk factors for substance abuse,
the attentive clinician lays the foundation for timely and productive conversation about risky
behaviors, should the situation arise. The patient-provider relationship is one valuable
component of the complex support system needed for establishment of maintenance of long-term
recovery from adduction.
The demographic findings of this study allow the clinician to identify individuals in his or
her practice at high risk for substance use. For example, recent divorcees or members of the LGB
community reporting emotional difficulties or a history of substance abuse may be targeted for
further screening and counseling.
For clinicians who wish to combat addiction on a community level, advocacy of
integration of general medical care and behavioral health services is encouraged wherever
possible. Integrated services may expand access, maximize convenience, and increase patient
compliance by making healthcare a ‘one-stop-shop’. The Protecting Access to Medicare Act
provides guidelines for the establishment of Certified Community Behavioral Health Clinics,
which serve as a model for the integration of physical and behavioral health services (SAMHSA,
2016b).
Strengths
An abundance of research exists describing demographic variables in relation to
substance abuse, but this study contributes to the body of knowledge regarding PPR misuse
specifically. As agencies nationwide continue to combat the opioid epidemic, specific
information regarding the PPR-misusing population is valuable.
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Limitations
Existing literature studies the interplay of demographic characteristics and their effects on
substance use, e.g., gender and educational level. This analysis does not include crossexamination of the interaction between demographic characteristics, making it difficult to parse
out the effects of a single demographic variable on PPR misuse.
Additionally, data regarding the degree of treatment engagement is absent from this
study. Though an individual may report current enrollment in addiction treatment, there may be
significant variability in the type of treatment, the number of appointments kept, medication
compliance, and other indicators of treatment engagement. Thus, enrollment in treatment may
not necessarily represent the attainment of favorable recovery outcomes.
Areas for Future Research
NSDUH data is limited on the misuse of PPRs and illicit drugs in individuals older than
age 65. The older population comprises a large portion of chronic pain patients, raising questions
about PPR use and misuse among elders. The association of age and income with treatmentseeking deserves further study to maximize recovery outcomes for the full spectrum of age and
socioeconomic status.
Demographic profiles of the PPR-misusing population provide a snapshot of the opioid
epidemic but must be considered in the dynamic context of families. Future research may
explore the later implications for children growing up with parents living with drug addiction.
ACE research addresses traumatic events, but the results of cumulative daily stress/influence of a
family member’s addiction warrants further investigation. In combination with continued
research on the effects of social support (especially from family members), these efforts would
contribute to the body of knowledge surrounding generational cycles of addiction.
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Social stigmatization poses a barrier to many PPR misusers considering treatment,
suggesting that continued efforts toward widespread acceptance of addiction as a disease, rather
than a moral failing, are warranted. Research regarding the efficacy of destigmatization strategies
among both health professionals and community members would be valuable in developing
evidence-based interventions. Conversion of the societal attitude toward addiction from
prejudice to support will foster a favorable environment for recovery at the community level.
Conclusion
The opioid crisis in the United States has brought to light the indiscriminate and
unforgiving nature of addiction. This demographic analysis of PPR misusers and treatment
enrollee identified high-risk characteristics, which represent groups to be targeted by individual
clinicians and public health professionals alike. Such characteristics include homosexuality,
divorce, male gender, age between 18-34, and a high school diploma or GED as the highest level
of education. These characteristics reflect groups with unique psychological and socioeconomic
stressors, predisposing to substance abuse. Multifaceted partnership between healthcare facilities,
public health agencies, and community members is crucial to minimizing barriers to addiction
treatment and ensuring care for the PPR-misusing population.
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Appendix B – Information from Table 5, Visualized in a Series of Charts

Percent of category

100%
80%
60%
40%
20%
0%

Financial

Personal

Program
Availability

Transport

Reason for Not Seeking Treatment
Male

Female

Percent of category

Figure 1. Reasons for non-treatment seeking by gender.
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Figure 2. Reasons for non-treatment seeking by sexuality.
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Figure 3. Reasons for non-treatment seeking by education level.
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Figure 4. Reasons for non-treatment seeking by age group.
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Figure 5. Reasons for non-treatment seeking by race.
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Figure 6. Reasons for non-treatment seeking by yearly income range (thousands of dollars per
year).
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Appendix C – List of Competencies Met in Integrative Learning Experience
Wright State Program Public Health Competencies Checklist
Identify and describe the 10 Essential Public Health Services that serve as the basis for public health
performance.
Assess and utilize quantitative and qualitative data.
Apply analytical reasoning and methods in data analysis to describe the health of a community.
Apply behavior theory and disease prevention models to develop community health promotion and
intervention programs.
Describe how policies, systems, and environment affect the health of populations.
Communicate public health information to lay and/or professional audiences with linguistic and cultural
sensitivity.
Address population diversity when developing policies, programs, and services.
Engage with community members and stakeholders using individual, team, and organizational opportunities.
Make evidence-informed decisions in public health practice.
Evaluate and interpret evidence, including strengths, limitations, and practical implications.
Demonstrate ethical standards in research, data collection and management, data analysis, and
communication.
Explain public health as part of a larger inter-related system of organizations that influence the health of
populations at local, national, and global levels.

Concentration Specific Competencies Checklist
Population Health Concentration
Explain a population health approach to improving health status
Use evidence-based problem solving in the context of a particular population health challenge.
Demonstrate application of an advanced qualitative or quantitative research methodology.
Demonstrate the ability to contextualize and integrate knowledge of a specific population health issue.
Evaluate population health programs or policies that are designed to improve the health of the population,
reduce disparities, or increase equity.
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